Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preclinical data discussed this week support clinical trials with thioplatin

April 9, 2002

European Commission designates E21R orphan drug in JMML

April 9, 2002

Adherex and AstraZeneca extend Exherin collaboration agreement

April 9, 2002

Independent review and long-term follow-up of phase II Orathecin study

April 9, 2002

Orally active VEGF receptor tyrosine kinase-selective agent presented at AACR meeting

April 9, 2002

Favorable pharmacokinetic profile seen for novel tyrosine kinase inhibitor CHIR-200131

April 9, 2002

Flt-3 kinase inhibitors and potential for treatment of AML discussed in Orlando by Millennium

April 9, 2002

LAQ-824: a potential new antitumor agent acting via inhibition of histone deacetylase

April 9, 2002

Promising profile reported at AACR meeting for novel histone deacetylase inhibitor CG-1521

April 9, 2002

Phase II studies of TOCOSOL Paclitaxel initiated

April 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...